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Viable porcine arteriviruses with deletions proximal to the
3« end of the genome
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In order to obtain attenuated live vaccine candidates of porcine reproductive and respiratory
syndrome virus (PRRSV), a series of deletions was introduced at the 3« end of the viral genome
using an infectious cDNA clone of the Lelystad virus isolate. RNA transcripts from the full-length
cDNA clones were transfected into BHK-21 cells. The culture supernatant of these cells was
subsequently used to infect porcine alveolar macrophages to detect the production of progeny
virus. It is shown that C-terminal truncation of the nucleocapsid (N) protein, encoded by ORF7, was
tolerated for up to six amino acids without blocking the production of infectious virus. Mutants
containing larger deletions produced neither virus nor virus-like particles containing viral RNA.
Deletion analysis of the 3« UTR immediately downstream of ORF7 showed that infectious virus was
still produced after removal of seven nucleotides behind the stop codon of ORF7. Deletion of 32
nucleotides in this region abolished RNA replication and, consequently, no infectious virus was
formed. Serial passage on porcine alveolar macrophages demonstrated that the viable deletion
mutants were genetically stable at the site of mutation. In addition, the deletions did not affect the
growth properties of the recombinant viruses in vitro, while their antigenic profiles were similar to
that of wild-type virus. Immunoprecipitation experiments with the six-residue N protein-deletion
mutant confirmed that the truncated protein was indeed smaller than the wild-type N protein. The
deletion mutants produced in this study are interesting candidate vaccines to prevent PRRS
disease in pigs.
Introduction
Porcine reproductive and respiratory syndrome virus
(PRRSV) is an enveloped, positive-strand RNA virus that
belongs to the family Arteriviridae, together with equine
arteritis virus (EAV), lactate dehydrogenase-elevating virus
(LDV) and simian haemorrhagic fever virus (SHFV)
(Meulenberg et al., 1993b). The family Arteriviridae has been
grouped within the order Nidovirales together with the family
Coronaviridae (Cavanagh, 1997). PRRSV has a single-stranded,
polyadenylated RNA genome of about 15 kb that contains at
least nine partially overlapping open reading frames (ORFs).
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ORFs1a and 1b encode the viral replicase genes, which are
expressed from the genomic RNA. The other, smaller ORFs
are located at the 3« end of the genome and are expressed from
subgenomic (sg) RNAs. These are produced as a 3«-nested set
during replication (de Vries et al., 1990 ; Meulenberg et al.,
1993a) and encode the structural proteins. ORF7 encodes the
nucleocapsid protein, N, ORF6 encodes the membrane protein,
M, ORF5 encodes the major envelope glycoprotein, GP
&
, and
ORFs 2–4 encode the minor envelope glycoproteins, GP
#
, GP
$
and GP
%
(Meulenberg et al., 1995). Recently, a novel structural
protein, E, was described for EAV (Snijder et al., 1999). This
protein is translated from sg mRNA2, which also encodes GP
#
.
For vaccine purposes, we aim to generate viable deletion
mutants of PRRSV. This raises basic questions about the
regions of the viral genome in which deletions are tolerated. In
this respect, two considerations are important. Firstly, PRRSV
has a concise genome, like other RNA viruses. Since RNA
viruses have evolved to optimal fitness, most of the genetic
information is expected to be essential. Secondly, the ORFs
that encode the structural proteins of the virus are partially
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overlapping. Deletions in overlapping regions would therefore
result in the mutation of two structural proteins, which would
almost inevitably lead to the production of a non-viable virus.
Earlier studies showed that deletions in many conserved
regions were lethal (M. H. Verheije, unpublished results).
In this study, we focused on the 3« end of the PRRSV
genome, since this region does not contain sequences that
overlap other ORFs. Until now, deletions introduced in the N-
terminal and middle parts of the coding region of the N protein
have not resulted in viable virus (M. H. Verheije, unpublished
results). In the present study, we were more successful by
focusing on the region around the N gene stop codon.
Alignment of the N protein sequence and the 3« UTR of
different PRRSV strains revealed heterogeneity at the C
terminus of the N protein and at the 5« end of the 3« UTR. A
deletion analysis of this region was therefore performed using
the available infectious cDNA clone (Meulenberg et al.,
1998a) of Lelystad virus (LV) in order to determine the limits
of the sequences that can be removed while still resulting in the
production of a viable virus, but one with reduced patho-
genicity. This is the first publication to describe the generation
of viable arterivirus mutants that contain a deletion in the viral
genome that is maintained stably after multiple passages in
vitro.
Methods
+ Cells and viruses. BHK-21 cells were grown in BHK-21 medium
(Gibco BRL) supplemented with 5% FBS, 10% tryptose phosphate broth
(Gibco BRL), 20 mM HEPES–NaOH (Gibco BRL), pH 7–4, 200 mM
glutamine, 10 U}ml penicillin, 10 lg}ml streptomycin, 20 lg}ml kana-
mycin, 5 lg}ml polymyxin B and 0–2 lg}ml fungizone. Porcine alveolar
lung macrophages (PAMs) were maintained in MCA-RPMI-1640
Table 1. Primers used to introduce deletions by PCR and to sequence the introduced mutations
The orientation of the primers (› and fi for sense and antisense) and the location of each primer with respect to the nucleotide sequence of LV
(GenBank accession no. M96262) are indicated. Restriction sites are underlined.
Primer Sequence (5«–3«) Orientation Purpose* Location
119R218R ATGACATCCGGCACCACC › Sequencing 14782
LV20 CCTGATTAAAAGCTTGACCCC fi Sequencing 15066
LV75 TCTAGGAATTCTAGACGATCG fi XbaI site 15088
LV155 ACGTGCGTTAACCTCGTCAAGTATGGCCGGTAAAAACCAGAGCCAGA › HpaI site 14582
LV204 ACGTGCTTAATTAACCTTGACTGGCGGATGTAGA fi pABV639 14974
LV213 TGCAAGTTAATTAAGGTGAATGGCCGCGA › pABV693 14996
LV214 GACTGTTTAATTAACTGGCGGATGTA fi pABV694 14958
LV215 GACTGTTTAATTAAGTCACGCGAATC fi pABV695 14942
LV239 TGCAAGTTAATTAAGCCTCTGAGTCA › pABV729 15021
LV263 GACTGTTTAATTAAGCGGATGTAGA fi pABV745 14954
LV264 GACTGTTTAATTAAGATGTAGAAGTC fi pABV746 14951
LV265 GACTGTTTAATTAAGTAGAAGTCACG fi pABV747 14948
LV266 GACTGTTTAATTAAGAAGTCACGCGA fi pABV748 14945
* Use of a primer in plasmid construction is indicated by the plasmid name.
medium containing 10% FBS, 100 lg}ml kanamycin, 50 U}ml penicillin,
50 lg}ml streptomycin, 25 lg}ml polymyxin B and 1 lg}ml fungizone.
Serial passage of the recombinant PRRS viruses was performed by
inoculation of 500 ll of the culture supernatant of transfected BHK-21
cells onto 1‹10( PAMs. The inoculum was removed after 1 h and 5 ml
fresh medium was added. The culture supernatant containing the
produced virus was harvested when the first signs of cytopathic effect
were observed, generally around 48 h after infection. The virus was
further passaged by repeatedly inoculating 500 ll of the harvested
culture medium of the previous passage onto 1‹10( PAMs and again
harvesting the culture supernatant after 48 h. Virus titres (expressed as
TCID
&!
}ml) were determined on PAMs by end-point dilution
(Wensvoort et al., 1986).
+ Construction of full-length genomic cDNA clones of LV. PCR
mutagenesis was used to introduce sequences into the PacI mutant of the
genome-length cDNA clone of LV (pABV437) (Meulenberg et al.,
1998a). The primers used for PCR mutagenesis are listed in Table 1. PCR
fragments generated to introduce deletions into ORF7 were digested
with HpaI and PacI and ligated into these sites of pABV437. PCR
fragments generated to introduce deletions into the 3« UTR were
digested with PacI and XbaI and ligated into these sites of pABV437.
Standard cloning procedures were performed essentially as described
previously (Sambrook et al., 1989). Transformation conditions were
maintained as described previously (Meulenberg et al., 1998a). Sequence
analysis was performed to confirm the introduced mutations. The
constructs are drawn schematically in Fig. 2.
+ Sequence analysis. The regions of the full-length cDNA clones
that originated from the PCR products were analysed by nucleotide
sequencing. Sequences were determined with the PRISM Ready Dye
Deoxy Terminator cycle sequencing kit and the ABI PRISM 310 Genetic
Analyser (Perkin Elmer).
+ In vitro transcription and transfection of BHK-21 cells. Full-
length genomic cDNA clones were transcribed in vitro and the resulting
RNA was transfected into BHK-21 cells either using Lipofectin (Gibco
BRL) or by electroporation (Meulenberg et al., 1998a).
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+ Infection of PAMs. To rescue infectious virus, the culture
supernatant of BHK-21 cells was harvested 24 h after transfection and
200 ll of this culture supernatant was used to inoculate PAMs. After 1 h,
the inoculum was removed and fresh culture medium was added.
Approximately 15 h after infection, the culture supernatant was harvested
and PAMs were washed with PBS, dried and stored at fi20 °C until the
immunoperoxidase monolayer assay was performed.
+ Immunoperoxidase monolayer assay (IPMA). Immunostaining
of BHK-21 cells and PAMs was performed by methods described
previously (Wensvoort et al., 1986). MAbs against GP
$
(122.14), GP
%
(122.1) and the M protein (126.3) (van Nieuwstadt et al., 1996) and
against the different antigenic domains of the N protein [138.22 (domain
A), 126.9 (domain B), 126.15 (domain C) and 122.17 (domain D) ;
Meulenberg et al., 1998b] were used to detect expression of PRRSV
proteins.
+ Genetic analysis of genomic RNA of recombinant viruses. In
order to analyse the viral RNA in the culture supernatant of PAMs and
in the fractions of the sucrose gradient, 200 ll of the culture supernatant
or of the fraction was diluted with an equal volume of proteinase K buffer
(100 mM Tris–HCl, pH 7–2, 25 mM EDTA, 300 mM NaCl, 2% w}v
SDS) and 0–08 mg proteinase K was added. After incubation for 30 min
at 37 °C, the RNA was extracted with phenol–chloroform and pre-
cipitated with ethanol. The RNA was reverse-transcribed with primer
LV76 and PCR was performed with primers 119R218R and LV20, which
flank the region of the viral genome that contained the deletions.
Amplified fragments were analysed in 2% agarose gels and the PCR
fragments were excised from the gel and purified with SpinX columns
(Costar). Sequence analysis of the fragments was performed using the
antisense primer of the PCR.
+ Radioimmunoprecipitation (RIP). Metabolic labelling and
immunoprecipitation of proteins expressed in PAMs were performed
essentially as described previously (Meulenberg & Petersen-den Besten,
1996). MAb 122.17 was used to immunoprecipitate the N protein. PAMs
were infected with passage 5 of the viruses at an m.o.i. of 1 and were
labelled for 4 h with Tran[35-S] label (ICN) at 15 h post-infection.
Samples were analysed by SDS–PAGE using a 14% acrylamide gel.
+ Virus concentration and purification. In order to analyse the
production of (non-infectious) virus particles, BHK-21 cells were
electroporated with RNA transcripts from pABV747 and pABV437 and,
15 h after transfection, the cells were labelled metabolically with 75 ll
10–5 mCi}ml Tran[35-S] label (ICN) for 24 h (Meulenberg & Petersen-
den Besten, 1996). The particles in the supernatant were concentrated by
centrifuging the supernatant through a 0–5 M sucrose cushion at
26000 r.p.m. for 5 h at 4 °C (Meulenberg & Petersen-den Besten, 1996).
The pellet was resuspended in TNE buffer (0–01 M Tris–HCl, pH 7–2,
0–1 M NaCl and 1 mM EDTA, pH 8–0) and layered onto a 20–50%
sucrose gradient (van Berlo et al., 1982). The sucrose gradient was
centrifuged at 32000 r.p.m. for 19 h at 4 °C. Fractions of 0–5 ml were
collected from bottom to top and 5 ll aliquots of the fractions were
analysed by SDS–PAGE using a 14% acrylamide gel.
Results
Sequence comparison of the N proteins and 3« UTRs of
PRRSV strains LV and VR2332
Since PRRSV is an RNA virus with a very concise genome,
most of its genetic information is expected to be essential.
Therefore, genomic cDNA clones containing deletions, es-
pecially in the conserved regions, generally do not produce
infectious transcripts (M. H. Verheije, unpublished results). In
order to identify regions of heterogeneity, where deletions
might be tolerated, sequence comparisons were performed.
The ORF7 gene at the 3« end of the LV genome was selected
because this ORF does not overlap with other ORFs. Amino
acid alignments of the N protein sequence encoded by ORF7
of the prototype European strain (Lelystad virus, LV) and the
prototype North American strain (VR2332 ; Murtaugh et al.,
1995) showed 60% overall identity (recently reviewed by Dea
et al., 2000). At the C terminus of the N protein, the amino acid
sequence is highly conserved up to residue 119 of LV.
Downstream of this conserved region, a short stretch without
amino acid conservation occurs. In addition, the C-terminal
part of the N protein of LV is four amino acids longer than that
of VR2332 (Fig. 1A). It was therefore anticipated that deletions
in the heterogeneous C terminus of the N protein of LV might
be tolerated, and this region was selected as a target to
introduce deletions.
Further nucleotide sequence comparison of the 3« UTR
downstream of ORF7 also revealed interesting differences
(Allende et al., 1999). The 11 5«-most nucleotides of the 3« UTR
of LV showed no identity to the first nucleotides of VR2332
(Fig. 1B). Directly downstream of these nucleotides, a stretch
of 38 nucleotides is present in VR2332 that has no counterpart
in LV. In contrast, high sequence conservation was observed
further downstream. In view of this heterogeneity, the region
directly downstream of the stop codon of ORF7 was also
selected as a target site for deletion studies.
LV accepts C-terminal truncations of up to six amino
acids of the N protein
cDNA clones with deletions in the sequence encoding the
two (pABV639), four (pABV694) and nine (pABV695) C-
terminal amino acids of the N protein were constructed by
PCR mutagenesis and cloning of the PCR fragments into an
infectious cDNA clone of LV containing a PacI site at the stop
codon of ORF7 (Meulenberg et al., 1998a) (Fig. 2). RNA
transcripts of these constructs were transfected into BHK-21
cells and tested for their ability to replicate by analysing the
expression of the structural proteins in IPMA (Fig. 2). All
transcripts expressed the viral proteins GP
$
, GP
%
and M. In
order to analyse the expression of the N protein, and in
particular its antigenic domains (Meulenberg et al., 1998b), we
used MAbs 138.22, against antigenic domain A, 126.9, against
domain B, 126.15, against domain C, and 122.17, against
domain D of the protein in IPMA. For all constructs, we found
that the transfected cells could be stained with each of the
MAbs. These results indicated that LV genomes containing
deletions at the C terminus of the N protein still replicated and
that the structural proteins were properly translated. In
addition, these deletions did not disturb the antigenic domains
of the N protein.
In order to investigate whether the LV mutants with a C-
terminally truncated N protein produced infectious virus, we
inoculated PAMs with culture supernatants of the transfected
CGAJ
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Fig. 1. Alignments of the N protein amino
acid sequences (A) and the 3« UTR
nucleotide sequences (B) of PRRSV LV
and VR2332. LV (GenBank accession no.
M96262) and VR2332 (U87392) are
the prototype European and North
American PRRSV strains. Conserved
residues are indicated by asterisks
beneath the alignments. In (B), part of
the PacI site present in the 3« UTR is
underlined.
Fig. 2. Design and analysis of the deletion mutants of recombinant cDNA clones of PRRSV. Deletions were introduced by PCR
mutagenesis and cloned into the full-length cDNA clone pABV437 (Meulenberg et al., 1998a). The constructs, deleted
nucleotides, plasmid numbers, observed expression of M and N protein and the production of viable virus are indicated. Boxes
indicate regions that were present ; lines indicate deleted regions. Expression of viral proteins M and N was analysed by IPMA
24 h after transfection of BHK-21 cells using MAbs 126.3 and 122.17, respectively. Positive staining is indicated by › ; no
staining is indicated by fi. The bar above the constructs indicates the antigenic domains of the N protein.
BHK-21 cells, as PRRSV cannot infect BHK-21 cells. Twenty-
four h later, the cells were fixed and stained with PRRSV-
specific MAbs. PAMs inoculated with the supernatant of BHK-
21 cells transfected with transcripts of pABV437, pABV639 or
pABV694 stained positive. In contrast, no staining of PAMs
was observed after inoculation with supernatant from BHK-21
cells transfected with RNA transcripts from pABV695. In
conclusion, LV mutants producing an N protein with a C-
terminal deletion of up to four amino acids produced infectious
virus, whereas mutants producing an N protein with a C-
terminal deletion of nine amino acids did not produce infectious
virus at all.
In order to define further the acceptable limits of truncation
of the N protein, we made stepwise deletions in the region
encoding the five to eight most C-terminal amino acids. The
fragments generated by PCR mutagenesis were again intro-
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duced into pABV437, resulting in pABV745, 746, 747 and
748, encoding N proteins lacking five, six, seven and eight C-
terminal amino acids (Fig. 2). Transfection of their RNA
transcripts into BHK-21 cells resulted in the expression of the
structural proteins for all constructs, as detected by IPMA.
After infection of PAMs with the culture supernatant of the
transfected BHK-21 cells, we only detected expression of the
structural proteins for vABV745 and vABV746. For mutants
lacking the region encoding the C-terminal seven amino acids
or more, no staining was observed in IPMA. These results
indicate that the maximum region that can be deleted at the 3«
end of ORF7 without abolishing the production of infectious
virus comprises 18 nucleotides, encoding the six C-terminal
residues of the N protein. The virus produced by this deletion
mutant (vABV746) was found to express the set of N protein
epitopes, as demonstrated by using our panel of MAbs (data
not shown).
Deletion of seven but not of 32 nucleotides at the 5«
end of the 3« UTR of LV is tolerated
In view of the observed nucleotide sequence variation in
the 3« UTR of the PRRSV genome downstream of ORF7 (Fig.
1B), we also investigated how deletion of these nucleotides
would affect the infection process. Deletions were again
introduced by PCR mutagenesis and the PCR fragments were
introduced into pABV437, directly behind the PacI site at the
stop codon of ORF7. The first four nucleotides of the 3« UTR
were left intact, as they are part of this PacI site. This resulted
in the plasmids pABV693, which has a deletion of seven
nucleotides, and pABV729, in which a deletion of 32
nucleotides occurs at the 5« end of the 3« UTR. BHK-21 cells
transfected with transcripts of pABV693 expressed the
structural proteins. However, BHK-21 cells transfected with
transcripts of pABV729 did not express these structural
proteins to levels detectable by IPMA, suggesting that RNA
replication and}or transcription did not occur. Subsequent
infection of PAMs with the culture supernatant of the BHK-21
cells that had been transfected with pABV693 showed
expression of the structural proteins in IPMA 24 h after
infection. These results demonstrated that at least seven
nucleotides at the 5« end of the 3« UTR are dispensable for the
virus to remain infectious.
Analysis of the stability and growth characteristics of
vABV746 and vABV693 in vitro
In order to investigate whether the deletions in the viruses
generated from pABV746 and pABV693 were maintained
stably in vitro, these viruses were serially passaged on PAMs.
After five passages, viral RNA was isolated from the culture
supernatant and studied by genetic analysis. The RNA was
reverse-transcribed and the region flanking the introduced
deletions was amplified by PCR. Sequence analysis of the
fragments showed that the introduced deletionwas still present
in both cases (data not shown) and that no additional mutations
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Fig. 3. Growth curves in PAMs of wild-type virus vABV437 (+) and of
mutant viruses vABV693 (U) and vABV746 (‹). PAMs were infected in
duplicate with passage 5 of the indicated viruses at an m.o.i. of 0–05 and
virus was harvested at the indicated time-points. Virus titres were
determined by end-point dilution on PAMs (Wensvoort et al., 1986).
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Fig. 4. Analysis of the N proteins expressed by the wild-type virus
vABV437 and by the six-amino-acid N protein-deletion mutant vABV746.
Proteins were immunoprecipitated from lysates of PAMs infected with
passage 5 of vABV437 and vABV746. Labelling was performed for 4 h
starting at 15 h after infection. The immunoprecipitated proteins were
analysed by SDS–PAGE in a 14% acrylamide gel. Molecular masses of the
marker proteins are indicated on the left.
had been introduced in the flanking regions. These results
indicated that the deletions had been maintained stably during
in vitro passaging on PAMs.
The growth characteristics of viruses vABV746 and
vABV693 were investigated by determining their growth
curves and comparing them with that of wild-type vABV437.
PAMs were infected with viruses from passage 5 at an m.o.i. of
0–05 and samples were taken from the culture media at various
time-points. Virus titres were determined by end-point dilution
on macrophages. As is clear from Fig. 3, no significant
CGBB
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Fig. 5. Analysis of the supernatant of
BHK-21 cells transfected with pABV747
and pABV437. Fifteen h after
transfection, the cells were labelled for
24 h using 75 ll 10–5 mCi/ml Tran[35-S]
label. Particles in the supernatant were
concentrated and fractionated as
described in Methods. (A) Proteins in the
fractions were analysed by 14%
SDS–PAGE. (B) RNA was isolated from
the fractions and analysed by RT–PCR, for
which the primers flanked the region in
which the deletion was introduced. The
sizes of the markers are indicated on the
left. Lane ›, positive PCR control.
differences in growth rates could be observed between
recombinant viruses and wild-type virus.
Analysis of the truncated N protein of vABV746
In order to confirm the effect of the deletion at the protein
level, the size of the N protein expressed by the recombinant
virus vABV746 was analysed by immunoprecipitation. PAMs
were infected and labelled metabolically with $&S-amino acids
and cell lysates were prepared. The N protein in the lysates
was precipitated with MAb 122.17, which is directed against
the D domain of the protein, and analysed by SDS–PAGE. As
expected, an N protein of wild-type size (15 kDa) was
immunoprecipitated from lysates of cells transfected with
vABV437 (Fig. 4), whereas a protein with an estimated size of
14 kDa was immunoprecipitated from vABV746-infected cell
lysates (Fig. 4). The smaller N protein expressed by vABV746
is consistent with the six-residue truncation compared with
wild-type vABV437.
Analysis of particle assembly after N protein
truncation
The abrupt transition in viability upon deletion of more
than six C-terminal amino acids may occur for various reasons.
We analysed whether the life cycle of the virus was disturbed
at the stage of virus assembly. To this end, BHK-21 cells were
transfected with RNA transcripts from pABV747 and proteins
were labelled for 24 h starting at 15 h after transfection. Virus
particles released into the culture supernatant were concen-
trated by centrifugation through a sucrose cushion and purified
further by equilibrium centrifugation in a sucrose gradient and
fractions of this gradient were analysed by SDS-PAGE.
Structural proteins of the appropriate size were detected for
the positive control pABV437 in fractions 5, 6 and 7. These
structural proteins were, however, not detected in any of the
fractions of pABV747 (Fig. 5A). In order to confirm the
absence of packaged RNA in these fractions, we isolated the
viral RNA from each fraction and performed RT–PCR. In none
of the fractions was a PRRSV-specific PCR fragment detected,
in contrast to the gradient run with pABV437-derived material
(Fig. 5B). In each of these fractions, two PCR fragments were
observed, in contrast to the lane in which we used cDNA of
pABV437 as a template. The second band derived from the
fractions could not be identified, however. It might have been
derived from deleted, packaged RNAs, resulting in the
production of heteroclite sg mRNAs (Yuan et al., 2000). The
absence of virus particles or virus-like particles produced by
transcripts of pABV747 suggests that virus assembly is
disturbed in this mutant.
Discussion
With the eventual aim of obtaining live attenuated PRRSV
vaccine candidates, this study describes the construction and
analysis of several virus deletion mutants. In view of the
genetic variability at the 3« end of the PRRSV genome, we
have tested the effect of deletions in this variable region. We
report that constructs lacking the coding sequence for up to six
C-terminal amino acids of the LV N protein still yielded
infectious virus after transfection of their transcripts into BHK-
21 cells. In contrast, further deletions were fully detrimental :
the removal of just one additional residue abolished the
production of viable virus completely. Furthermore, deletions
were also tolerated directly downstream of the stop codon of
ORF7. At least seven nucleotides in this region were
dispensable for virus production ; removal of 32 nucleotides
was, however, fatal. Both the virus with a six amino acid
truncation of the N protein and the virus with the seven
nucleotide deletion in the 3« UTR had in vitro growth
characteristics and antigenic profiles similar to those of wild-
type virus. Moreover, these viruses were both genetically
stable.
The dramatic effect of truncation at the seventh residue of
the LV N protein was quite surprising and was not predicted
by the sequence. The sequence of the nine C-terminal residues
of the LV N protein is very different from that of the VR2332
isolate except for its high content of hydroxy amino acids. In
the LV and VR2332 N proteins, six of ten and three of six
residues, respectively, at the very C terminus are serines or
threonines. The functions of this domain and of these particular
residues are unknown. Two other arteriviruses, LDV and
CGBC
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SHFV, also contain hydroxy amino acids at the extreme C
terminus of their N proteins, namely 3}10 and 4}10 amino
acids, respectively. In contrast, hydroxy amino acids are
completely absent from the last ten amino acids of the EAV N
protein. While coronavirus N proteins do generally have a
relatively high serine content (7–11%; Masters & Sturman,
1990), the proportion of serines and threonines at their C
termini is quite insignificant ; in these viruses, this region is
markedly acidic. Obviously, these variable characteristics do
not allow predictions about the role of the C terminus of the N
protein in the virus life cycle. The truncated N protein had the
same antigenic profile as that of the wild-type N protein, since
it reacted with all MAbs directed against antigenic domains of
the N protein. This is consistent with observations by
Meulenberg et al. (1998b), who identified that domain D, the
most C-terminal domain of N, is a conformation-dependent or
discontinuous epitope that involves amino acids 51–67 and
80–90.
Virus particle production appeared to be blocked after
truncation of the LV N protein by seven amino acids. This
indicates strongly a defect at the level of virus assembly. For a
Canadian PRRSV isolate, it has been demonstrated that non-
covalent interactions between the C-terminal regions of N
proteins are critical for formation of the isometric capsid
protein (Wootton & Yoo, 1999). In a system expressing only
the N protein, they showed that the last 11 amino acids were
involved in these interactions. This might indicate that the C
terminus of PRRSV is essential for nucleocapsid formation.
Our study supports this idea. Other effects of C-terminal
truncation of the N protein can, however, not be excluded, as
the N protein has been implicated in various other processes,
such as interaction with the viral RNA [Dea et al., 2000 ; for
mouse hepatitis virus (MHV), see Cologna & Hogue, 1998 ;
Molenkamp & Spaan, 1997] and interaction with other viral
proteins (for MHV, see Narayanan et al., 2000). Since it has
been described for MHV, the best-studied coronavirus, that a
29 amino acid deletion in the putative spacer region preceding
the C-terminal domain of the N protein resulted in
temperature-sensitive and thermolabile viruses (Peng et al.,
1995), we investigated whether our deletion mutants had
similar characteristics ; they appeared not to have these
characteristics. Moreover, infectious virus was still not pro-
duced from the deletion mutants expressing truncated N
proteins lacking seven amino acids or more after the incubation
temperature was lowered to 30 °C. In an earlier study, we
demonstrated that extension of the C terminus of the N
protein by a nine amino acid sequence of the influenza virus
HA protein significantly impaired virus growth (Groot Bramel-
Verheije et al., 2000). We could not establish whether this was
caused by disturbance of virus assembly or disassembly,
however. Again, these observations are consistent with the C-
terminal region of the LV N protein being involved in N–N
interactions essential for the production of nucleocapsids
during virus assembly.
RNA viruses have at their termini non-coding sequences
that play essential roles in RNA replication and sg mRNA
transcription. Mutations in these domains are likely to affect
the virus life cycle. Consistently, when we introduced deletions
in the 5«-terminal region of the LV 3« UTR, we found that
removal of a small seven-nucleotide variable sequence was
accepted, while removal of a somewhat larger, 32-nucleotide
stretch was not. From the inability of the RNA transcripts to
express the M and N proteins, we conclude that the defect
probably resides in an effect on RNA replication or sg mRNA
transcription. This suggests that this region of the 3« UTR
contains an essential RNA signal. Our results are in accordance
with studies on coronaviruses, which showed that the 5«
terminus of the 3« UTR is essential in the initial processes of the
virus life cycle (Hsue et al., 2000). No host or virus protein was
found to bind this region of the viral RNA specifically.
However, the exact function of this region remains to be
elucidated. Since deletion of the 3«-most 27 nucleotides of the
N gene did not abolish RNA replication, this region apparently
does not contain a replication signal similar to the one
observed within the 3«-terminal region of the EAV N gene
(Molenkamp et al., 2000).
In this study, we aimed to generate viable PRRSV mutants
with maximal deletions at the target site. The viruses obtained
were characterized in vitro and fulfilled the most important
requirements ; good growth and genetic stability. Because their
growth characteristics in vitro on PAMs were identical to those
of wild-type virus, virus production for in vivo studies can be
accomplished easily. The growth characteristics in vitro do not
necessarily correlate with or predict the behaviour of the virus
in vivo. Thus, many vaccines used currently are attenuated in
vivo, but show no differences in propagation in vitro (Yang et
al., 1998). Therefore, only animal experiments will tell how
these viruses behave in vivo, whether they are sufficiently
attenuated and whether they induce immune responses that
will protect against infection with virulent PRRSV.
We thank E. van Wijk for technical assistance and P. van Rijn for
critical reading of the manuscript. This workwas supported by Boehringer
Ingelheim, Germany.
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